Evidence map›Paper›PMID 27003602›Full record

ArticleGastroenterology2016

Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity.

Frank I Scott, Daniel B Horton, Ronac Mamtani, Kevin Haynes, David S Goldberg, Dale Y Lee, James D Lewis

Abstract read
In one paragraph

Article in Gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Observational
  19. Observational
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Frank I ScottDivision of Gastroenterology, Department of Medicine, University of Colorado Denver, Aurora, Colorado; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: frank.i.scott@ucdenver.edu.
Daniel B HortonCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Rheumatology, Nemours A.I. duPont Hospital for Children, Wilmington, Delaware; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
Ronac MamtaniDivision of Gastroenterology, Department of Medicine and Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Kevin HaynesCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
David S GoldbergCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Abramson Cancer Center, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Dale Y LeeDepartment of Gastroenterology, Seattle Children's Hospital, Seattle, Washington.
James D LewisCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Abramson Cancer Center, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Funding

Clinical Pharmacoepidemiology Training ProgramT32GM075766 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Sean Hennessy, Charles Edward Leonard · 2006 to 2026
$8.4M
Test-Treat strategy to prevent ulcerative colitis relapseK24DK078228 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LEWIS, JAMES D · 2007 to 2016
$1.9M
Insulin resistance in the development and progression of invasive bladder cancerK23CA187185 · NCI · UNIVERSITY OF PENNSYLVANIA · PI MAMTANI, RONAC · 2015 to 2019
$872k
A population-based cohort to study outcomes in end-stage liver disease patientsK08DK098272 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GOLDBERG, DAVID SETH · 2013 to 2017
$786k
Microvascular disease, statins, ACE-inhibitors and post-operative SBOK08DK095951 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI SCOTT, FRANK IRVING · 2012 to 2016
$771k
Glucocorticoid use and osteonecrosis in chronic pediatric inflammatory diseasesF32AR066461 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI HORTON, DANIEL BENJAMIN · 2014 to 2014
$74k
NCI NIH HHS K23 CA187185NIAMS NIH HHS F32 AR066461NIDDK NIH HHS K08 DK095951NIDDK NIH HHS K08 DK098272NIDDK NIH HHS K24 DK078228NIGMS NIH HHS T32 GM075766
6 · The paper itself

Abstract

BACKGROUND &

aimsChildhood obesity is increasing and is associated with adult obesity. Antibiotics have been used to promote weight gain in livestock for several decades. Antibiotics are commonly prescribed for children, but it is not clear how exposure to antibiotics early in life affects risk for obesity. We performed a population-based cohort study to assess the association between antibiotic exposure before age 2 years and obesity at age 4 years.

methodsWe performed a retrospective cohort study of 21,714 children in The Health Improvement Network-a population-representative dataset of >10 million individuals derived from electronic medical records from 1995 through 2013 in the United Kingdom. Eligible subjects were registered within 3 months of birth with complete follow-up and height and weight were recorded within 12 months of their 4th birthday. Antibiotic exposure was assessed before age 2 years, and classified based on anti-anaerobic activity. The primary outcome was obesity at age 4 years. We performed logistic regression analyses, adjusting for maternal and sibling obesity, maternal diabetes, mode of delivery, socioeconomic status, year and country of birth, and urban dwelling.

resultsIn the cohort, 1306 of the children (6.4%) were obese at 4 years of age. Antibiotic exposure was associated with an increased risk of obesity at 4 years (odds ratio [OR] = 1.21; 95% confidence interval [CI]: 1.07-1.38). ORs increased with repeated exposures: for 1-2 prescriptions, OR = 1.07 (95% CI, 0.91-1.23); for 3-5 prescriptions, OR = 1.41 (95% CI, 1.20-1.65); and for 6 or more prescriptions, OR = 1.47 (95% CI, 1.19-1.82). Antifungal agents were not associated with obesity (OR = 0.81; 95% CI, 0.59-1.11).

conclusionsAdministration of 3 or more courses of antibiotics before children reach an age of 2 years is associated with an increased risk of early childhood obesity.

Indexed as

Age FactorsAnti-Bacterial AgentsAntifungal AgentsChild, PreschoolFemaleHumansInfantLogistic ModelsMaleOdds RatioPediatric ObesityRetrospective StudiesRisk FactorsUnited KingdomAnti-Bacterial AgentsAntifungal AgentsMicrobiomePediatricsTHINUK

Identifiers

PMID27003602
PMCPMC4924569

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.